ES2174445T3 - Nueva clase de agentes transfectantes cationicos de los acidos nucleicos. - Google Patents

Nueva clase de agentes transfectantes cationicos de los acidos nucleicos.

Info

Publication number
ES2174445T3
ES2174445T3 ES98928418T ES98928418T ES2174445T3 ES 2174445 T3 ES2174445 T3 ES 2174445T3 ES 98928418 T ES98928418 T ES 98928418T ES 98928418 T ES98928418 T ES 98928418T ES 2174445 T3 ES2174445 T3 ES 2174445T3
Authority
ES
Spain
Prior art keywords
cluster
inclusive
hydrogen atom
nucleic acids
new class
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98928418T
Other languages
English (en)
Inventor
Michel Bessodes
Daniel Scherman
Jean Herscovici
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of ES2174445T3 publication Critical patent/ES2174445T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18Acyclic radicals, substituted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Agente transfectante que comprende al menos una región hidrófila catiónica, acoplada con una región lipófila, caracterizada porque la citada región hidrófila catiónica tiene como fórmula general: en la que - y es un número entero igual a 0 o 1, siendo independientes entre sí los diferentes y, - X representa un átomo de oxígeno, de nitrógeno, de azufre o de selenio, - los agrupamientos Z representan, independientemente entre sí, un átomo de hidrógeno, un agrupamiento OR, en que R representa un átomo de hidrógeno, un agrupamiento metilo, o un agrupamiento (CH2)n- NR1R2, en el que n es un número entero elegido de 1 a 6 inclusive y R1 y R2 representan, independien- temente entre sí, un átomo de hidrógeno o un agrupamiento (CH2)q-NH2, pudiendo variar q de 1 a 6 inclusive, siendo independientes entre sí, los diferentes q, un agrupamiento (CH2)m-NR1R2, en el que m es un número entero elegido de 0 a 6 inclusive y R1 y R2 se definen como anteriormente, o bien un agrupamiento "espaciador" que permitala unión de la región hidrófila catiónica con la región lipófila, entendiéndose que al menos uno de los substituyentes Z es un agrupamiento "espaciador" y que al menos de los substituyentes Z portan un agrupamiento amino.
ES98928418T 1997-06-06 1998-06-03 Nueva clase de agentes transfectantes cationicos de los acidos nucleicos. Expired - Lifetime ES2174445T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9707014A FR2764304B1 (fr) 1997-06-06 1997-06-06 Nouvelle classe d'agents transfectants cationiques des acides nucleiques

Publications (1)

Publication Number Publication Date
ES2174445T3 true ES2174445T3 (es) 2002-11-01

Family

ID=9507684

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98928418T Expired - Lifetime ES2174445T3 (es) 1997-06-06 1998-06-03 Nueva clase de agentes transfectantes cationicos de los acidos nucleicos.

Country Status (18)

Country Link
EP (1) EP0986568B1 (es)
JP (1) JP2002504815A (es)
KR (1) KR20010013312A (es)
CN (1) CN1259134A (es)
AT (1) ATE214708T1 (es)
AU (1) AU737579B2 (es)
BR (1) BR9809953A (es)
CA (1) CA2292837A1 (es)
DE (1) DE69804302T2 (es)
DK (1) DK0986568T3 (es)
ES (1) ES2174445T3 (es)
FR (1) FR2764304B1 (es)
HU (1) HUP0004577A3 (es)
NO (1) NO314147B1 (es)
PL (1) PL337177A1 (es)
PT (1) PT986568E (es)
WO (1) WO1998055490A1 (es)
ZA (1) ZA984845B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999012945A2 (en) * 1997-09-08 1999-03-18 Valentis,Inc. Hydrophobic glycosylamine derivatives, compositions, and methods for use
DE19942864A1 (de) * 1999-09-08 2001-03-15 Knoell Hans Forschung Ev Neue O-(Aminoalkyl)-Derivate von Monosacchariden, Verfahren zu ihrer Herstellung und ihre Verwendung als antibakterielle Mittel
JP4629333B2 (ja) * 2001-08-29 2011-02-09 アベンティス・ファーマ・ソシエテ・アノニム アミノグリコシドの脂質誘導体
FR2829136B1 (fr) * 2001-08-29 2006-11-17 Aventis Pharma Sa Derives lipidiques d'aminoglycosides
DK2027137T3 (en) 2005-06-08 2015-05-18 Amicus Therapeutics Inc Imino and aminosugar PURIFICATION
WO2008081686A1 (ja) * 2006-12-28 2008-07-10 Konica Minolta Holdings, Inc. コレステロール誘導体、リポソーム、リポソームの形成方法およびx線用造影剤
WO2017151733A1 (en) * 2016-03-01 2017-09-08 Molecular Transfer, Inc. Plant virus movement proteins and methods of using the same
CN112384523A (zh) * 2018-05-16 2021-02-19 川斯勒佰尔公司 核糖阳离子脂质
JP2021534196A (ja) 2018-08-23 2021-12-09 シージェン インコーポレイテッド 抗tigit抗体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2774417B2 (ja) * 1991-08-07 1998-07-09 株式会社ディ・ディ・エス研究所 ペプチド骨格を有する分枝鎖型糖複合体及び微粒子キャリヤー
DE4329093A1 (de) * 1993-08-30 1995-03-02 Bayer Ag Substituierte Aminoalkylglycoside
AU4923696A (en) * 1995-02-10 1996-08-27 Nexstar Pharmaceuticals, Inc. Lipid constructs for cytoplasmic delivery of agents

Also Published As

Publication number Publication date
AU737579B2 (en) 2001-08-23
EP0986568A1 (fr) 2000-03-22
AU8025098A (en) 1998-12-21
EP0986568B1 (fr) 2002-03-20
FR2764304B1 (fr) 1999-07-16
HUP0004577A3 (en) 2003-03-28
NO995858L (no) 1999-11-30
BR9809953A (pt) 2000-08-01
CN1259134A (zh) 2000-07-05
WO1998055490A1 (fr) 1998-12-10
FR2764304A1 (fr) 1998-12-11
DK0986568T3 (da) 2002-06-10
ATE214708T1 (de) 2002-04-15
PT986568E (pt) 2002-08-30
JP2002504815A (ja) 2002-02-12
ZA984845B (en) 1998-12-29
NO995858D0 (no) 1999-11-30
KR20010013312A (ko) 2001-02-26
CA2292837A1 (fr) 1998-12-10
NO314147B1 (no) 2003-02-03
DE69804302D1 (de) 2002-04-25
HUP0004577A1 (hu) 2001-04-28
DE69804302T2 (de) 2002-10-17
PL337177A1 (en) 2000-08-14

Similar Documents

Publication Publication Date Title
CY1109439T1 (el) Αναλογα γλυκοπρωτεϊνικων ορμονων δισουλφιδικης σταυρωτης συνδεσης, η παρασκευη και η χρηση τους
AR013230A1 (es) Citolisis dirigida de celulas blanco, agentes y composiciones que la provocan y compuestos que se pueden emplear para producir dichos agentes
DK0495053T3 (da) Ny linker til bioaktive midler
ES2036551T3 (es) Compuestos heterociclicos.
ES2151185T3 (es) Lipopoliaminas como agentes de transfeccion y sus aplicaciones farmaceuticas.
ES2196305T3 (es) Composiciones que contienen moleculas inmunogenas y factor de estimulacion de colonias de granulocitos magrofagos como adyuvante.
ES2175631T3 (es) Dispositivo para la aplicacion de mechas de un producto capilar.
DE69024965D1 (de) Dehydrodidemnin b
FI930991A0 (fi) Polymerer som innehaoller diesterenheter
SE9703289D0 (sv) Stabilisatorkombination
DE50210313D1 (de) Amphotere sterole und deren verwendung
ES2174445T3 (es) Nueva clase de agentes transfectantes cationicos de los acidos nucleicos.
ES2122275T3 (es) Derivados amidicos de la vitamina d.
FR2718963B1 (fr) Nouvelle composition pharmaceutique à base de taxoïdes.
PA8461601A1 (es) Isoquinolinas
ES2042556T3 (es) N,n'-diacilhidrazinas n-sustituidas, n'-sustituidas insecticidas.
ATE263659T1 (de) Manipulator
ATE440960T1 (de) T-helferzellen-epitope
ES2056153T3 (es) Expectorante que comprende un derivado hidroxialquilcisteina.
DE69132689T2 (de) Biologisch aktive amine
DE3561153D1 (de) Benzoylurea derivatives
BG92842A (bg) Метод за получаване на бета-карбонил-карбоксиамиди на 1,3-тиазолидини
HUP0300198A2 (hu) Tiokolkicin és bakkatin kondenzációs származékai és ilyen vegyületeket tartalmazó, tumor elleni hatású gyógyászati készítmények
FI822937A0 (fi) Saett att dispergera gas, omroera pulverformigt fast material i en vaetska till en suspension och uppehaolla i reaktorn den goda fastmaterial-gas-vaetskesuspensionen som aostadkommits
SE8205535D0 (sv) Kvaternera piperidiniumhalider

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 986568

Country of ref document: ES